Ten Years of Growth Hormone (GH) Replacement Normalizes Muscle Strength in GH-Deficient Adults
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
CONTEXT: GH replacement for 1-5 yr improves, but does not fully normalize, muscle strength. OBJECTIVE, DESIGN, AND PATIENTS: In this single-center, open-labeled, prospective study, the effects of 10 yr of GH replacement on muscle strength and neuromuscular function were followed in 109 consecutive adults (61 men; mean age 50.0 yr; range 22-74 yr) with adult-onset GH deficiency. RESULTS: The mean initial GH dose of 0.88 mg/d was gradually lowered to 0.47 mg/d. The mean IGF-I sd score increased from -1.54 at baseline to 1.12 at study end. GH replacement induced a sustained increase in lean mass and isometric knee flexor strength (60 degrees). In most other measures of upper leg and handgrip strength, there were transient increases during the first half of the study (0-5 yr), whereas during the second half (5-10 yr), the absolute values of muscle strength decreased and returned to or even below the baseline values. However, after correction for age and gender using observed/predicted value ratios, there were sustained and, until 7 yr, even progressive increases in the measures of muscle strength. At study end, knee flexor strength had increased to 104-110% of predicted, knee extensor strength to 93-108%, and handgrip strength to 88-93%. Measurements of neuromuscular function showed reduced voluntary motor unit activation after 10 yr. CONCLUSIONS: Ten years of GH replacement therapy increased muscle strength during the first half of the study and thereafter partly protected against the normal age-related decline in muscle strength and neuromuscular function, resulting in approximately normalized muscle strength after 10 yr.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, research has not consistently reported cardiovascular risk profile improvement (171).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [171]
Citations
Cites
The physical activity scale for the elderly (PASE): Development and evaluation
Washburn, R. A., Smith, K. W., Jette, A. M., & Janney, C. A. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90053-4 · Cited by 3,177
Muscle strength and speed of movement in relation to age and muscle morphology
Larsson, L., Grimby, G., & Karlsson, J. (1979) · Journal of Applied Physiology · doi:10.1152/jappl.1979.46.3.451 · Cited by 1,135
BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS
Jørgensen, J. O. L., Thuesen, L., Ingemann-Hansen, T., Pedersen, S. A., Jørgensen, I., Skakkebaek, N. E., & Christiansen, J. S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92328-3 · Cited by 890
Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance
Cuneo, R. C., Salomon, F., Wiles, C. M., Hesp, R., & Sonksen, P. H. (1991) · Journal of Applied Physiology · doi:10.1152/jappl.1991.70.2.695 · Cited by 342
Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength
Cuneo, R. C., Salomon, F., Wiles, C. M., Hesp, R., & Sonksen, P. H. (1991) · Journal of Applied Physiology · doi:10.1152/jappl.1991.70.2.688 · Cited by 334
Fatiguability and Fibre Composition of Human Skeletal Muscle
Thorstensson, A., & Karlsson, J. (1976) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1976.tb10316.x · Cited by 328
Nordenskiöld, U. M., & Grimby, G. (1993) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749309095105 · Cited by 328
The Effects of 10 Years of Recombinant Human Growth Hormone (GH) in Adult GH-Deficient Patients
Gibney, J. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2596 · Cited by 324
Rutherford, O. M., Jones, D. A., & Newham, D. J. (1986) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.49.11.1288 · Cited by 296
Impact of muscle power and force on gait speed in disabled older men and women
Cuoco, A., Callahan, D. M., Sayers, S., Frontera, W. R., Bean, J., & Fielding, R. A. (2004) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/59.11.1200 · Cited by 283
Research works printed but not linked: 1
- Rutherford, 1994, Quadriceps strength before and after growth hormone replacement in hypopituitary adults: relationship to changes in lean body mass and IGF-I., Endocrinol Metab, 1, 41
Cited by
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Perrini, S., Laviola, L., Carreira, M. C., Cignarelli, A., Natalicchio, A., & Giorgino, F. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0431 · Cited by 317
“In line with these observations, a recent 10-year GH replacement trial in GHD adults has shown that the increased muscle strength and improved neuromuscular function are more evident in younger subjects than in older subjects (Götherström et al. 2009).”
ResultEndocrine Parameters and Phenotypes of the Growth Hormone Receptor Gene Disrupted (GHR−/−) Mouse
List, E. O., Sackmann-Sala, L., Berryman, D. E., Funk, K., Kelder, B., Gosney, E. S., Okada, S., Ding, J., Cruz-Topete, D., & Kopchick, J. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0009 · Cited by 181
Wilkinson, C. W., Pagulayan, K. F., Petrie, E. C., Mayer, C. L., Colasurdo, E. A., Shofer, J. B., Hart, K. L., Hoff, D., Tarabochia, M. A., & Peskind, E. R. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00011 · Cited by 162
“GH replacement also normalizes muscle strength and increases bone mineral density (Götherström et al., 2007b, 2009), improves psychiatric functioning by ameliorating depression, intensity of interpersonal sensitivity, hostility, paranoid ideation, and anxiety (Maric et al., 2010), and improves QoL…”
BackgroundAction of GH on skeletal muscle function: molecular and metabolic mechanisms
Chikani, V., & Ho, K. K. Y. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0208 · Cited by 120
Metadata
- Authors
- Götherström, G., Elbornsson, M., Stibrant-Sunnerhagen, K., Bengtsson, B.-A., Johannsson, G., & Svensson, J.
- Affiliations
- Research Center for Endocrinology and Metabolism (G.G., M.E., B.-Å.B., G.J., J.S.), Institute of Neuroscience and Physiology, Göteborg University, SE-413 45 Göteborg, Sweden
- University of Gothenburg (SE)
- Sahlgrenska University Hospital, and Research Group for Rehabilitation Medicine (K.S.-S.), Institute of Neuroscience and Physiology, Göteborg University, SE-413 45 Göteborg, Sweden
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2009-03-01
- Volume
- 94
- Issue
- 3
- Pages
- 809-816
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2063946301
- Semantic Scholar
- 5bb22ee9e97645258750b94fb5fcf0803e16f691
- Cited by
- 85
- References
- 41
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 1 · 2022: 3 · 2021: 3 · 2020: 4 · 2018: 7 · 2017: 2 · 2016: 3 · 2015: 4 · 2014: 5 · 2013: 14 · 2012: 9
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- growth hormone replacement therapy, adult-onset growth hormone deficiency, muscle strength, hamstring strength, quadriceps strength, grip strength, insulin-like growth factor I, lean body mass, neuromuscular function, age-related muscle strength decline
- MeSH terms
- Adrenocorticotropic Hormone, Adult, Age Factors, Aged, Body Composition, Female, Humans, Insulin-Like Growth Factor I, Male, Middle Aged, Prospective Studies, Sex Characteristics, Thyrotropin, Human Growth Hormone, Hormone Replacement Therapy, Muscle Strength
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ten Years of Growth Hormone (GH) Replacement Normalizes Muscle Strength in GH-Deficient Adults. https://app.cochat.ai/papers/10.1210/jc.2008-1538
- The paper
- Götherström, G., Elbornsson, M., Stibrant-Sunnerhagen, K., Bengtsson, B.-A., Johannsson, G., & Svensson, J. (2009). Ten Years of Growth Hormone (GH) Replacement Normalizes Muscle Strength in GH-Deficient Adults. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2008-1538
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.